Results hosted on duckduckgo.com
Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses.
Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the European Union.
Synthetic cannabinoid receptor agonists (commonly referred to as ‘synthetic cannabinoids’) are a group of substances that mimic the effects of (–)-trans-Δ9-tetrahydrocannabinol (THC), which is the substance that is primarily responsible for the major psychoactive effects of cannabis. Like THC, the synthetic cannabinoids bind to the cannabinoid receptors in the body.
Current knowledge on synthetic cannabinoids and trends in production, availability, use and harms are presented in this designed-for-the-web analysis. This resource also includes an interactive feature aimed at demystifying the the chemistry of the synthetic cannabinoids.
Synthetic cannabinoids in EuropePublications by the EMCDDA on this topic
EMCDDA activities, services and tools on this topic
Photos, infographics and videos from our Media library
